🇪🇺 UPC
UPC_CFI_1934/2026
Court
Brussels Local Division
Type of action
revocation
Language
en
Claimant / applicant
- Establishment Labs S.A.
- 2SEVENTY BIO, INC.
Defendant / respondent
- S.L.U. GC Aesthetics GmbH GC Aesthetics Holdings Limited GC Aesthetics Finance Limited Romed NV
- JANSSEN BIOTECH, INC.
- JANSSEN PHARMACEUTICALS INC.
- JANSSEN-CILAG INTERNATIONAL NV
- JANSSEN PHARMACEUTICA NV
- JANSSEN-CILAG NV
- JANSSEN BIOLOGICS B.V.
- JANSSEN-CILAG A/S
- JANSSEN-CILAG FARMACEUTICA LDA.
- LEGEND BIOTECH CORPORATION
- LEGEND BIOTECH USA INC.
- LEGEND BIOTECH IRELAND LIMITED; AND
- LEGEND BIOTECH BELGIUM BV
Track this case
Get an email when a new order or decision is published in UPC_CFI_1934/2026.
Decisions and documents (1)
- 2026-06-08procedural
- Claimant:
- 2SEVENTY BIO, INC.
- Defendants:
- JANSSEN BIOLOGICS B.V.; JANSSEN BIOTECH, INC.; JANSSEN PHARMACEUTICA NV; JANSSEN PHARMACEUTICALS INC.; JANSSEN-CILAG A/S; JANSSEN-CILAG AKTIEBOLAG; JANSSEN-CILAG B.V.; JANSSEN-CILAG FARMACEUTICA LDA.; JANSSEN-CILAG GMBH; JANSSEN-CILAG INTERNATIONAL NV; JANSSEN-CILAG NV; JANSSEN-CILAG SAS; JANSSEN-CILAG SPA; LEGEND BIOTECH BELGIUM BV; LEGEND BIOTECH CORPORATION; LEGEND BIOTECH IRELAND LIMITED; AND; LEGEND BIOTECH USA INC.
Counterclaim for revocation. Document: ORD(I)_R37_UPC_CFI_029-1934_1940-2026_Signed.pdf. Case page: https://www.unifiedpatentcourt.org/en/node/183486
• Panel: Samuel Granata
Weekly digest
A weekly email summarising new published decisions across European patent courts.